A University of Southern California cancer physicist is on a quest to develop a mapping tool for cancer, including Multiple Myeloma that is as easy to use as the Google Maps or Waze mobile apps.
The U.S. Food and Drug Administration recently announced a collaboration agreement with Kuhn, who founded the USC Michelson Center initiative CSI-Cancer. Dr. Kuhn, Dean’s Professor of Biological Sciences at USC Dornsife, is looking to determine which patients will respond to a treatment and which patients won’t through a detailed analysis of patient data.
The project centers on creating computational models that could predict how breast cancer patients would respond to specific treatments. Kuhn and his team will analyze the data sets with machine learning and algorithms to then generate computational models.